Publication Beamlines Strategic Pillar
Jason Chin; Nicolas HUGUENIN-DEZOT; Mohan MAHESH; Shan Tang; Duy P. Nguyen et al. (2022). Methods and compositions. Patent Number: US20220010296A1. CMCF-ID Health
Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. CMCF-ID Health
Jian; Mike (2020). Molecular Basis for the Cross-Species Specificity of the Anti-Serum Albumin Vhh M79. Supervisor: Brooks, Cory L.. California, USA: California State University, Fresno. https://search.proquest.com/docview/2419103999. CMCF-ID Health
Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Patricia Anne GIBLIN; Jeanne MAGRAM et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: US20210187106A1. CMCF-ID Health
Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: US20210253691A1. CMCF-ID Health
Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. CMCF-ID Health
Kalliokoski, Tuomo; Kettunen, Henna; Kumpulainen, Esa; Kettunen, Emilia; Thieulin-Pardo, Gabriel et al. (2023). Discovery of novel methionine adenosyltransferase 2A (MAT2A) allosteric inhibitors by structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters 94, 129450. 10.1016/j.bmcl.2023.129450. [PDB: 8p1t, 8p1v] CMCF-ID Health
Kassardjian, A.; Julien, J.P. (2024). Crystal structure of humanized 44H10 Fab Version 22 in complex with HLA-DR (HLA-DRA*01:01/HLA-DRB1*04:01). Protein Data Bank: 9b7b. CMCF-ID Health
Kassardjian, Audrey; Ivanochko, Danton; Barber, Brian; Jetha, Arif; Julien, Jean-Philippe et al. (2024). Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. Antibodies 13(3) , 57. 10.3390/antib13030057. [PDB: 9b7b] CMCF-ID Health
Kattar, Solomon D.; Gulati, Anmol; Margrey, Kaila A.; Keylor, Mitchell H.; Ardolino, Michael et al. (2023). Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson’s Disease. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.3c01486. [PDB: 8six] CMCF-ID Health
Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning ZHAO; John Lippincott (2024). Antibodies to tigit. Patent Number: US20240182570A1. CMCF-ID Health
Ketcham, John M.; Harwood, Stephen J.; Aranda, Ruth; Aloiau, Athenea N.; Bobek, Briana M. et al. (2024). Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c00078. [PDB: 8v8h] CMCF-ID Health
Keylor, Mitchell H.; Gulati, Anmol; Kattar, Solomon D.; Johnson, Rebecca E.; Chau, Ryan W. et al. (2021). Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors. Journal of Medicinal Chemistry 65(1) , 838-856. 10.1021/acs.jmedchem.1c01968. [PDB: 7suh] CMCF-ID Health
Khan, J.A. (2021). CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-benzyl-2-oxa-7,13,14-triazatetracyclo[14.3.1.1^{3,6}.1^{11,14}]docosa-1(19),11(21),12,16(20),17-pentaen-10-yl]-3~{H}-triazolo[4,5-b]pyridin-5-amine. Protein Data Bank: 7lan. CMCF-ID Health
Khan, J.A. (2021). CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-14 AKA 7-({1-[(3-phenoxyphenyl)methyl]-1H-pyrazol-4-yl}methyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine. Protein Data Bank: 7lag. CMCF-ID Health